Top Oncology Companies
290 Oncology companies, sorted by total funding raised.
A2 Biotherapeutics advances its Tmod cell engineering platform to create precision CAR T-cell the...
Precision oncology company developing first-in-class small molecule therapies that reactivate mut...

MEI Pharma is a clinical-stage pharmaceutical company developing novel small-molecule drug candid...

Callio Therapeutics is a clinical-stage biotech developing dual-payload antibody-drug conjugates,...
Black Diamond discovers and develops next-wave precision cancer medicines to treat patients with ...
Numab designs and develops a new class of powerful therapeutics for the treatment of severe disea...

Commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines th...
A precision oncology company developing highly targeted cancer therapies focused on genomic insta...
Focused on acquiring, developing and commercializing innovative anti-cancer agents in the US, Eur...
Precision oncology company developing innovative medicines targeting areas of high unmet need in ...
Pioneering the next generation of large molecule precision therapeutics to deliver new life-savin...
Elephas Biosciences' elive™ platform is designed to provide real-time functional response predict...

Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural ...
Biopharma startup developing cancer treatments based on human immune response.

Precision oncology company developing structure-based cancer therapies.
Innovative ADC drug development company focused on next-generation antibody-drug conjugates for c...
Storm Therapeutics is a Cambridge biotechnology company pioneering RNA epigenetics, with first-in...
Clinical-stage biotech developing targeted and immunotherapies for cancer treatment.
Clinical-stage allogeneic T-cell immunotherapy company developing off-the-shelf cell therapies fo...
Clinical-stage immunotherapy company developing the Flare platform to expand curative potential o...
German-domiciled and NASDAQ-traded company developing a variety of immuno-oncology therapeutics.
Biotech developing precision cancer therapies.
Vyriad is a clinical-stage biotechnology company developing the next generation of targeted genet...
